Literature DB >> 14764316

Value of clinical data and neuropsychological measures in probable Alzheimer's disease.

Roberto Gallassi1, Angela Morreale, Rita Di Sarro, Sebastiano Lorusso.   

Abstract

We examined retrospectively 60 probable Alzheimer's disease (AD) outpatients, 30 with early onset (EOP) and 30 with late onset (LOP), divided into two groups on the basis of illness duration (within 2 years (P<2) and over 2 years (P>2)), compared with 60 normal controls (NC). We employed a battery of neuropsychological tests including the mini mental state examination (MMSE) and our brief mental deterioration battery (BMDB), computerized psychomotor performance tests and staging of functional impairment. EOP were worse than LOP in verbal fluency and in functional impairment, being better only in Rey's long-term verbal memory (RLT). P>2 were more compromised than P<2 in functional impairment, MMSE, personal and temporal orientation and RLT. Our BMDB showed the highest accuracy in classifying probably AD patients, whereas, MMSE had a high specificity but poor sensitivity as well as psychomotor performance tasks. In conclusion, AD patients with early onset, having a worse functional impairment, appear to be an eligible group to evaluate possible changes in response to antidementia treatment.

Entities:  

Year:  2002        PMID: 14764316     DOI: 10.1016/s0167-4943(01)00204-7

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  6 in total

1.  Are subjective cognitive complaints a risk factor for dementia?

Authors:  Roberto Gallassi; Federico Oppi; Roberto Poda; Simona Scortichini; Michelangelo Stanzani Maserati; Gianfranco Marano; Luisa Sambati
Journal:  Neurol Sci       Date:  2010-02-25       Impact factor: 3.307

2.  Slowly progressive aphemia: a neuropsychological, conventional, and functional MRI study.

Authors:  R Gallassi; L Sambati; R Poda; F Oppi; M Stanzani Maserati; D Cevolani; R Agati; R Lodi
Journal:  Neurol Sci       Date:  2011-05-24       Impact factor: 3.307

3.  Effects on cognition of 20-day anodal transcranial direct current stimulation over the left dorsolateral prefrontal cortex in patients affected by mild cognitive impairment: a case-control study.

Authors:  Enrico Fileccia; Vitantonio Di Stasi; Roberto Poda; Giovanni Rizzo; Michelangelo Stanzani-Maserati; Federico Oppi; Patrizia Avoni; Sabina Capellari; Rocco Liguori
Journal:  Neurol Sci       Date:  2019-05-07       Impact factor: 3.307

4.  Predicting conversion from mild cognitive impairment to Alzheimer's disease using brain 1H-MRS and volumetric changes: A two- year retrospective follow-up study.

Authors:  Micaela Mitolo; Michelangelo Stanzani-Maserati; Sabina Capellari; Claudia Testa; Paola Rucci; Roberto Poda; Federico Oppi; Roberto Gallassi; Luisa Sambati; Giovanni Rizzo; Piero Parchi; Stefania Evangelisti; Lia Talozzi; Caterina Tonon; Raffaele Lodi; Rocco Liguori
Journal:  Neuroimage Clin       Date:  2019-04-30       Impact factor: 4.881

5.  Relationship of white and gray matter abnormalities to clinical and genetic features in myotonic dystrophy type 1.

Authors:  Stefano Zanigni; Stefania Evangelisti; Maria Pia Giannoccaro; Federico Oppi; Roberto Poda; Antonio Giorgio; Claudia Testa; David Neil Manners; Patrizia Avoni; Laura Ludovica Gramegna; Nicola De Stefano; Raffaele Lodi; Caterina Tonon; Rocco Liguori
Journal:  Neuroimage Clin       Date:  2016-05-03       Impact factor: 4.881

6.  The Bologna motor and non-motor prospective study on parkinsonism at onset (BoProPark): study design and population.

Authors:  Giovanna Calandra-Buonaura; Luisa Sambati; Francesca Baschieri; Maria Vitiello; Manuela Contin; Caterina Tonon; Sabina Capellari; Federica Provini; Pietro Cortelli
Journal:  Neurol Sci       Date:  2020-03-26       Impact factor: 3.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.